list of glp 1 drugs GLP-1 Market Industry Trends and Global Forecasts 2024-2035: Over 150 GLP-1 Drug Candidates in Development for Multiple Indications, Type 2 Diabetes and Obesity Drive GLP-1 Drug Development Boom Market Overview: GLP-1 Agonists and

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.

The incretin pathway is a self-regulating feedback system connecting the gut with the brain, pancreas, and liver

A doctor explains what to do when you miss, run out or cant refill your medication

Yale Medicine experts explain who qualifies, who can prescribe, and what to expect.

Engineering new ligands that specifically target multiple G protein-coupled receptors with desired activity profiles requires time-consuming and expensive cycles of design-make-test-analyse work